Coronary Morphology and Conduction System Disturbance Induced by Therapeutic Embolization of the Coronary Septal Artery
Background: Percutaneous transluminal septal myocardial alcohol ablation (PTSMAA) is not a procedure without complications. It may produce heart arrhythmias, especially those due to disturbances of atrioventricular (AV) and interventricular (IV) electrical conduction.
Objective: The goal of this study was to evaluate the relationship between the anatomical patterns of the right coronary artery and the left anterior descending artery (LAD) and to relate them to the AV and IV bundle branch blocks provoked by PTSMAA.
Method: Twenty patients with obstructive hypertrophic cardiomyopathy resistant to treatment with drugs successfully underwent PTSMAA. Electrocardiographic analyses were done before and after PTSMAA, and the results were compared with the abnormal septal anatomy.
Results: The effectiveness of PTSMAA was obtained in 18 (90%) of the 20 patients by ethanolization of the first great septal branch. In the other 2 patients (10%), 2 septal branches underwent alcoholization. First-grade temporary AV block (AVB) was observed in 6 patients (30%). Ten patients experienced severe bradycardia due to total AVB that required a temporary pacemaker, but 3 of the patients (15%) required a permanent pacemaker. Fourteen patients (70%) experienced permanent complete right branch block, and 2 developed incomplete left anterior block and incomplete left posterior block. Six patients presented with no electrical conduction disturbance at all.
Conclusion: According to the results of the present investigation with the AV node artery derived from the right coronary artery in all cases, complete and permanent AV conduction system blockade occurred after PTSMAA in all types of anatomy regarding the observed LAD.
Alam M, Dokainish H, Lakkis N. 2006. Alcohol septal ablation for obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 19:319-27.nChahine RA. 1991. Surgical versus medical treatment of hypertrophic cardiomyopathy: Is the perspective changing? J Am Coll Cardiol 17:643-45.nChang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. 2003. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 42:296-300.nCoelho AA. 2008. Preditores angiográficos de alterações eletrocardiográficas após ablação septal percutânea [master's thesis]. Belo Horizonte, MG, Brazil: Fundação Cardiovascular São Francisco de Assis Verdade é Jesus; November 2008.nDidio LJA, Jatene FB. 2002. Sistema circulatório. In: Didio LJA, ed. Tratado de anatomia aplicada. São Paulo: Atheneu. p 325-35.nGuimarães JI, Nicolau JC, Pastore CA, et al. 2003. Diretriz de interpretação de eletrocardiogramade repouso. Arq Bras Cardiol 80(Suppl 2). Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003000800001. Accessed October 29, 2009. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003000800001'>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003000800001nKnight C, Kurbaan A, Seggewiss U, et al. 1997. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 95:2075-81.nKuhn H, Gietzen F, Leuner C, Gerenkamp T. 1997. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846-51.nLumb G, Singletary HP. 1962. Blood supply to the atrioventricular node and bundle of His. A comparative study in pig, dog and man. Am J Pathol 41:65-79.nMarin-Neto JA, Lima Filho MO, Schmidt A, Maciel BC, Tumelero R. 1998. Cardiomiopatia hipertrófica tratada por técnica intervencionista de redução septal. Arq Bras Cardiol 70:345-50.nOsterne ECV, Seixas TN, Paulo Filho W, Osterne EM, Gomes OM. 2003. Alcoolização septal transluminal percutânea no tratamento da cardiomiopatia hipertrófica obstrutiva refratária. Experi?ncia inicial no Distrito Federal. Arq Bras Cardiol 80:359-78.nOsterne ECV, Motta VP, Motta PAM, et al. 2004. Evolução em curto e médio prazo de pacientes submetidos à ablação septal com álcool no Distrito Federal. Rev Bras Cardiol Invas 12:116-20.nQin JX, Shiota T, Lever HM, et al. 2001. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38:1994-2000.nRodriguez FL, Robbins SL, Banasiewicz M. 1962. The descending septal artery in human, porcine, equine, ovine, bovine and canine hearts. A postmortem angiographic study. Am Heart J 62:247-59.nRunquist LA, Nielsen CD, Killip D, Gazes P, Spencer WH 3rd. 2002. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 90:1020-2.nSchlesinger MJ. 1938. An injection plus dissection study of coronary artery occlusions and anastomoses. Am Heart J 15:528-68.nSchlesinger MJ. 1948. Significant variations in the anatomic pattern on the coronary vessels. Circulation 13:61-72.nSigwart U. 1995. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211-4.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).